Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)
CNY 7.75
(-0.64%)
CNY 7.75
(-0.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 21.21 Million | 110.43 Million | 183.29 Million | 263.72 Million | 172.52 Million | 146.51 Million |
| Net Income | 96.4 Million | 202.64 Million | 395.13 Million | 151.28 Million | 147.55 Million | 283.16 Million |
| Depreciation & Amortization | 48.73 Million | 47.59 Million | 55.68 Million | 36.95 Million | 25.84 Million | 22.75 Million |
| Deferred income taxes | 23.9 Million | 49.26 Million | 24.91 Million | -1.97 Million | -1.68 Million | -3.23 Million |
| Stock-based compensation | - | 3.44 Million | - | 3.86 Million | 7.33 Million | 5.01 Million |
| Change in working capital | 37.78 Million | 75.69 Million | 57.49 Million | 102.13 Million | 30.95 Million | -127.11 Million |
| Other non-cash items | -161.72 Million | -268.22 Million | -325.01 Million | -28.54 Million | -37.47 Million | -32.28 Million |
| Investing Cash Flow | -86.26 Million | 32.39 Million | -662.46 Million | -347.38 Million | 51.6 Million | -1.02 Billion |
| Investments in PPE | -52.91 Million | -43.28 Million | -45.91 Million | -117.84 Million | -111.41 Million | -198 Million |
| Acquisitions | 30 Thousand | -4.42 Million | 15.25 Million | 206.16 Thousand | -32.73 Million | -59.26 Million |
| Investment purchases | -52.99 Million | -205.2 Million | -97.64 Million | -253.01 Million | -130 Million | -30 Million |
| Sales/Maturities of investments | 113.84 Million | 43.86 Million | 66.78 Million | 41.97 Million | 29.2 Million | 47.45 Million |
| Other Investing Activities | -94.22 Million | 241.43 Million | -600.94 Million | -18.7 Million | 296.55 Million | -784.99 Million |
| Financing Cash Flow | -41.39 Million | -80.15 Million | -31.3 Million | -31.63 Million | -8.09 Million | -23.43 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -41.39 Million | -80.87 Million | -31.3 Million | -30.01 Million | -58.09 Million | -57.6 Million |
| Common Stock Repurchased | - | - | - | -16.61 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 720 Thousand | - | 14.99 Million | 50 Million | 34.16 Million |
| Accounts receivables | 39.16 Million | 1.17 Million | 34.47 Million | 29.63 Million | 84.76 Million | -166.58 Million |
| Accounts payables | -7.32 Million | -8.7 Million | -38.42 Million | 63.89 Million | -62.82 Million | 74.03 Million |
| Inventory | -17.97 Million | 33.96 Million | 36.52 Million | 10.58 Million | 3.36 Million | -31.33 Million |
| Other working capital | 23.9 Million | 49.26 Million | 24.91 Million | -1.97 Million | 5.64 Million | -95.78 Million |
| Cash at beginning of period | 226.21 Million | 161.54 Million | 672.53 Million | 789.11 Million | 573.08 Million | 1.47 Billion |
| Cash at end of period | 120.16 Million | 226.21 Million | 161.54 Million | 672.53 Million | 789.11 Million | 573.08 Million |
| Capital Expenditure | -52.91 Million | -43.28 Million | -45.91 Million | -117.84 Million | -111.41 Million | -198 Million |
| Effect of forex changes on cash | 402.7 Thousand | 1.99 Million | -506.73 Thousand | -1.28 Million | 1.00 | 0.45 |
| Net cash flow / Change in cash | -106.04 Million | 64.66 Million | -510.98 Million | -116.58 Million | 216.02 Million | -901.72 Million |
| Free Cash Flow | -31.7 Million | 67.14 Million | 137.38 Million | 145.88 Million | 61.1 Million | -51.48 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 85.46 Million | -190.61 Million | 96.4 Million | -93.6 Million | -55.13 Million |
| Depreciation & Amortization | - | 12.68 Million | 12.68 Million | 48.73 Million | 11.74 Million | -25.24 Million |
| Deferred income taxes | - | - | - | 23.9 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 12.42 Million | - | 37.78 Million | 21.19 Million | 1.24 Million |
| Other non-cash items | - | -47.13 Million | 246.16 Million | -161.72 Million | 51.35 Million | 89.07 Million |
| Investing Cash Flow | 2.42 Million | -72.76 Million | -49.51 Million | -86.26 Million | -66.38 Million | -23.75 Million |
| Investments in PPE | -14.64 Million | -34.83 Million | -6.31 Million | -52.91 Million | -10.88 Million | -19.25 Million |
| Acquisitions | - | - | - | 30 Thousand | 885.34 Million | 20 Thousand |
| Investment purchases | - | -349.1 Million | - | -52.99 Million | -885.34 Million | -15 Million |
| Sales/Maturities of investments | 17.38 Million | 9 Million | 11.32 Million | 113.84 Million | 34.68 Million | 34.78 Million |
| Other Investing Activities | -319 Thousand | -46.94 Million | -54.52 Million | -94.22 Million | -90.18 Million | -24.29 Million |
| Financing Cash Flow | - | -10.58 Million | - | -41.39 Million | -5.48 Million | -1.8 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -10.58 Million | - | -41.39 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | 1.81 Million | - | 39.16 Million | 39.16 Million | -8.88 Million |
| Accounts payables | - | - | - | -7.32 Million | - | - |
| Inventory | - | 10.6 Million | - | -17.97 Million | -17.97 Million | 10.12 Million |
| Other working capital | - | - | - | 23.9 Million | - | - |
| Cash at beginning of period | 71.2 Million | 126.24 Million | 120.16 Million | 226.21 Million | 201.67 Million | 217.46 Million |
| Cash at end of period | 108.35 Million | 71.2 Million | 126.24 Million | 120.16 Million | 120.16 Million | 201.67 Million |
| Capital Expenditure | -14.64 Million | -34.83 Million | -6.31 Million | -52.91 Million | -10.88 Million | -19.25 Million |
| Effect of forex changes on cash | -412.61 Thousand | 108.64 Thousand | 42.01 Thousand | 402.7 Thousand | -330.47 Thousand | -156.71 Thousand |
| Net cash flow / Change in cash | 37.15 Million | -55.03 Million | 6.07 Million | -106.04 Million | -81.5 Million | -15.78 Million |
| Free Cash Flow | -14.64 Million | -9.18 Million | 49.23 Million | -31.7 Million | -20.18 Million | -9.32 Million |
DELTA
VANI
FDR
LHHOTEL
2497
002968